Cannabis
New York bans delta-8 THC, resists calls to track hemp like marijuana (Marijuana Business Daily)
Legal Marijuana States Have Generated Nearly $8 Billion In Tax Revenue Since Recreational Sales Launched, Report Finds (Marijuana Moment)
Minnesota: Governor Signs Legislation into Law to Legalize Medical Marijuana Flower (NORML)
Nevada: Lawmakers Send Multiple Marijuana Reform Measures to Governor’s Desk (NORML)
Cannabis emoji remains elusive: When it will exist, what it might look like, and why we don’t have one (yet) (GreenState)
Louisiana: House-Approved Marijuana Decriminalization Bill Heads to Senate Floor (NORML)
The Decriminalization of Marijuana in Brazil Beyond the Medicinal Use: Cannabis Associations and Human Rights (Chacruna)
Atheists Are Much More Likely To Back Marijuana Legalization Than Christians Are, New Poll Finds (Marijuana Moment)
LSD
Microdosing Psilocybin and LSD: Panacea or Placebo? (Spirit Pharmacist)
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing (Psilocybin Alpha)
Magic Mushrooms
Attorneys General Back Doctor on DEA Psilocybin Lawsuit (Truffle Report)
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms (Psilocybin Alpha)
María Sabina, Mushrooms, and Colonial Extractivism (Chacruna)
The Psilocybin vs. Escitalopram Trial – Part 1 (Psychedelic Science Review)
MDMA
The Effects of MDMA on Liver Health (Truffle Report)
DMT
Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke (Psilocybin Alpha)
Ayahuasca
When Ayahuasca Microdosing Might Cause Serotonin Toxicity (Chacruna)
Breathe Easy: Combining Albuterol & Ayahuasca (Spirit Pharmacist)
Iboga
Why Iboga Is Considered a Master Healer (Lucid News)
Novel Psychoactive Substances
Non-hallucinogenic psychedelic analog reverses effects of stress in mouse study (Science Daily)
Nitrous Oxide
London borough bans ‘laughing gas’ nitrous oxide over anti-social behaviour (The Independent)
Ketamine
Effort to limit ketamine use by Colorado paramedics, police advances toward governor’s desk (The Colorado Sun)
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease (Psilocybin Alpha)
PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations (Psilocybin Alpha)
Miscellaneous
Texas Senate Approves Psychedelics And Marijuana Concentrates Bills (Marijuana Moment)
Maine Lawmakers Advance Drug Decriminalization Bill To House Floor With Conflicting Recommendations (Marijuana Moment)
Psychedelics’ Exciting Potential to Benefit Autistic People (Filter)
Virtual Reality and Psychedelic Synergy (Psychedelic Science Review)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.